Kelly A Gebo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kelly A Gebo

Showing results (21-30 of 222) with videos related to

Pageof 23

Sort By:

Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004

Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?Seth Himelhoch, Richard D Moore, Glenn Treisman, et al.

American Journal of Public Health|June 16, 2012

HIV infection and older Americans: the public health perspectiveJohn T Brooks, Kate Buchacz, Kelly A Gebo, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005

The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy eraKelly A Gebo, Rita Kalyani, Richard D Moore, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012

Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008Stephen A Berry, John A Fleishman, Richard D Moore, et al.

AIDS (London, England)|February 28, 2008

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsJessica L Long, Eric A Engels, Richard D Moore, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002Richard D Moore, Jeanne C Keruly, Kelly A Gebo, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use statusRichard D Moore, Kelly A Gebo, Gregory M Lucas, et al.

AIDS (London, England)|April 20, 2002

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinicGregory M Lucas, Kelly A Gebo, Richard E Chaisson, et al.

Medical Care|November 11, 2010

The economic burden of late entry into medical care for patients with HIV infectionJohn A Fleishman, Baligh R Yehia, Richard D Moore, et al.

Medical Care|August 24, 2005

High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United StatesKelly A Gebo, John A Fleishman, Erin D Reilly, et al.

Pageof 23

Search research articles

Showing results (21-30 of 222) with videos related to

Sort By:

Pageof 23

Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2004

Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?Seth Himelhoch, Richard D Moore, Glenn Treisman, et al.

American Journal of Public Health|June 16, 2012

HIV infection and older Americans: the public health perspectiveJohn T Brooks, Kate Buchacz, Kelly A Gebo, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005

The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy eraKelly A Gebo, Rita Kalyani, Richard D Moore, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012

Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008Stephen A Berry, John A Fleishman, Richard D Moore, et al.

AIDS (London, England)|February 28, 2008

Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsJessica L Long, Eric A Engels, Richard D Moore, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002Richard D Moore, Jeanne C Keruly, Kelly A Gebo, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2008

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use statusRichard D Moore, Kelly A Gebo, Gregory M Lucas, et al.

AIDS (London, England)|April 20, 2002

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinicGregory M Lucas, Kelly A Gebo, Richard E Chaisson, et al.

Medical Care|November 11, 2010

The economic burden of late entry into medical care for patients with HIV infectionJohn A Fleishman, Baligh R Yehia, Richard D Moore, et al.

Medical Care|August 24, 2005

High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United StatesKelly A Gebo, John A Fleishman, Erin D Reilly, et al.

Pageof 23